CGRP monoclonal antibodies : summary and effectiveness - Migraine
Prevention of migraine with monoclonal antibodies against CGRP or the CGRP receptor, Neurological Research and Practice
Monoclonal antibodies against calcitonin gene-related peptide in chronic migraine: an adjusted indirect treatment comparison
What Are CGRP Inhibitors – Migraine Medication
CGRP monoclonal antibodies : summary and effectiveness - Migraine Canada™
CGRP as the target of new migraine therapies — successful translation from bench to clinic
Wearing-off” efficacy of CGRP monoclonal antibodies for migraine prevention: A meta-analysis of randomized controlled trials - Thanin Asawavichienjinda, Seelwan Sathitratanacheewin, Ronpichai Chokesuwattanaskul, 2023
Migraine monoclonal antibodies against CGRP change brain activity depending on ligand or receptor target – an fMRI study
Efficacy and safety of monoclonal antibody against calcitonin gene-related peptide or its receptor for migraine patients with prior preventive treatment failure: a network meta-analysis, The Journal of Headache and Pain
Aimovig (erenumab) for the Treatment of Episodic Migraine